Aiming to become the global leader in chip-scale photonic solutions by deploying Optical Interposer technology to enable the seamless integration of electronics and photonics for a broad range of vertical market applications

Free
Message: Stockhouse ad/article
Reply New Message
Prev Message Back To Forum Threaded View Next Message

Well ARKK has about 30 holdings, the smallest of which is FATE Therapeutics at a market value of $600k at 0.01% of the fund's weight. Just below NVDA with $5.3M and making up 0.09% of the weight. 

https://ark-funds.com/funds/arkk/

 

PRNT on the other hand contains about 50 companies. Includes such gems as PYRogenesis at $210k at 0.09%, just below Xerox at $201k and 0.11%. 

 

https://ark-funds.com/funds/prnt/

 

Despite the absolutely miserable performances of both funds, it would be a dream to have some consistent and sustained buying of such a fund. 

8 Recommendations
Reply New Message
Prev Message Back To Forum Threaded View Next Message
Share
Share
New Message
Please login to post a reply